利拉鲁肽联合替格瑞洛对老年2型糖尿病伴冠心病患者的临床疗效观察OA
Clinical Efficacy Observation of Liraglutide Combined with Ticagrelor in the Treatment of Elderly Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
目的:探讨利拉鲁肽联合替格瑞洛对老年2型糖尿病(T2DM)伴冠心病(CHD)患者的影响.方法:选取 2020 年 1 月—2021 年 1 月武汉中西医结合骨科医院收治的 70 例老年T2DM伴CHD患者为研究对象,按随机数字表法分为对照组(n=35)和研究组(n=35),对照组给予盐酸二甲双胍及替格瑞洛治疗,研究组给予利拉鲁肽联合替格瑞洛治疗,比较两组干预前后的血糖指标[空腹血糖(FPG)、糖化血红蛋白(HbA1c)]、心功能指标[左心室射血分…查看全部>>
Objective:To investigate the effect of Liraglutide combined with Ticagrelor on elderly patients with type 2 diabetes mellitus(T2DM)and coronary heart disease(CHD).Method:A total of 70 elderly patients with T2DM and CHD admitted to Wuhan Integrated Traditional Chinese and Western Medicine Orthopedic Hospital from January 2020 to January 2021 were selected as the study objects.They were divided into control group(n=35)and study group(n=35)according to random n…查看全部>>
舒盼
武汉中西医结合骨科医院中西结合内科 湖北 武汉 430000
利拉鲁肽替格瑞洛老年2型糖尿病冠心病
LiraglutideTicagrelorElderly type 2 diabetes mellitusCoronary heart disease
《中国医学创新》 2024 (24)
5-9,5
评论